Elekta Ab Class B · OMXSTO:EKTA_B

Elekta Ab Class B — FY2015/16 Earnings Presentation

23 slides from Elekta Ab Class B's earnings presentation, June 2016

  1. Slide 1: Year-end report 2015/16

    Year-end report 2015/16 Tomas Puusepp President and CEO Håkan Bergström Chief Financial Officer

  2. Slide 2: Important information

    Important information This presentation includes forward-looking statements including, but not limited to, statements relating to operational and financial performance, market conditions, and other similar matters. These forward-looking statements are based on current expectations about future event

  3. Slide 3: Operational and financial improvements in a challenging market environment

    Operational and financial improvements in a challenging market environment Net Sales Highlights 2015/16 SEK M › Large strategic wins in all regions › Positive order growth for the year › Improved margin – in a challenging market › Transformation program – in line with expectations › Solutions − MR-l

  4. Slide 4: Strong order bookings in Q4

    Strong order bookings in Q4 › Strategic wins in all regions: Q4 order bookings +16%* › Full year gross and net order bookings: +1%* › Challenging market conditions particularly in emerging markets › Net sales: decreased 3%* › EBITA: increased by 11% to SEK 1,639** M › Cost savings 2015/16: SEK 200 M

  5. Slide 5: 23% of order bookings in Q4 from large orders

    23% of order bookings in Q4 from large orders. Volatility between quarters will continue 4

  6. Slide 6: Growth in all regions

    Growth in all regions Gross order bookings North and South America Europe, Middle East and Africa Asia Pacific Stable replacement market in Large wins – NHSSC and Leeds Large agreement with Genesis USA driven by service Cancer Centre in UK, Medicana Care in Australia in Turkey China was flat Latin A

  7. Slide 7: China – market growth has leveled off

    China – market growth has leveled off Elekta net sales in China › Elekta is the market and technology leader − Strong product portfolio and supply chain − Proven management team › Growth has leveled off − Growth in 2015/16 was FX driven − Opportunity in service › New regulatory requirements has temp

  8. Slide 8: Elekta's installed base continues to grow

    Elekta’s installed base continues to grow - Good momentum in winning new business New orders New sockets* Installed base 7 Note: Order intake of linear accelerators in FY 2015/16 *New radiation therapy departments or expansion by new bunker

  9. Slide 9: Strong performance in service - LGK promising in Q4

    Strong performance in service - LGK promising in Q4 › Net sales in the service business grew by 11%* in FY › Leksell Gamma Knife business improved in Q4 − Excellent feedback from customers − Leksell Gamma Knife Society meeting in Amsterdam − Approval for Icon in Japan and NRC clearance in US (May/Ju

  10. Slide 10: Successful transformation program

    Successful transformation program › Leaner and more efficient operations › Improved financial efficiency, higher margins and lower net working capital › Strengthened innovation and customer satisfaction › Realized cost savings: SEK 200 M › Net working capital ratio at 2% (8) › The produce-to-order p

  11. Slide 11: On track to reach the targets

    On track to reach the targets EBITA margin of 20% by 2017/18 Cost reductions of Net working capital One-off negative to sales below revenue impact of SEK 700*M with full effect 5% SEK500 M 2017/18 by 2016/17 in H1 2016/17 10 *Base year 2014/15, excluding currency effects

  12. Slide 12: Financial update

    Financial update Håkan Bergström CFO

  13. Slide 13: Financial performance – fiscal year 2015/16

    Financial performance – fiscal year 2015/16 › Net sales: SEK 11,221 M, -3%* › EBITA: improved 11% to SEK 1,639** M − Cost savings of SEK 200 M › Gross margin: 41% (40) − Higher share of service and positive impact from FX › Expenses are trending down - operating expenses reduced by 4%*** › R&D expen

  14. Slide 14: Operational cash conversion at 111%

    Operational cash conversion at 111% Cash conversion (%) 140% 126% 120% 111% 100% 79% 80% 60% 60% 40% 20% 0% 2012/13 2013/14 2014/15 2015/16 Operational Cash Conversion* Target › Working capital reduced by SEK ~600 M › Cash outflow in transformation SEK 250 M 13 *Cash flow from operating activities /

  15. Slide 15: Net working capital to sales target reached

    Net working capital to sales target reached DSO* Days DSO* improved to 60 (76) days (Y/Y) North and South America -46 (-16) – Favorable product mix Europe, Middle East & Africa 112 (163) – Decrease in accounts receivable Asia Pacific 128 (95) Net working capital (MSEK) % of net sales – Increase in a

  16. Slide 16: Positive currency effect of SEK 150 M expected for 2016/17

    Positive currency effect of SEK 150 M expected for 2016/17 (Based on today’s currency rates) Currency effect for fiscal year 2016/17 › Net sales -2 percentage points › EBITA: SEK +150 M › Exchange rate differences SEK 0 M (vs SEK -165 M in FY 2015/16) 15

  17. Slide 17: Visibility going forward – gross orders and backlog maturity

    Visibility going forward – gross orders and backlog maturity › Industry benchmark: reflecting underlying market development › Backlog adjustments of 7% › Orders that are not expected to materialize as planned or cancelled are removed from the order backlog 40% › Historic gross and net order numbers

  18. Slide 18: Summary

    Summary Tomas Puusepp CEO

  19. Slide 19: Mix market dynamics - service grows in most markets

    Mix market dynamics - service grows in most markets Market development (indication) North America Replacement market. Hospital consolidation. South America Challenging conditions in Brazil. Western Europe Pent-up demand and private initiatives. Eastern Europe & Middle East Markets depending on the e

  20. Slide 20: Well positioned in attractive market

    Well positioned in attractive market Transformation Unique position Strong product program on track in long-term offering and leading driving operational growing market R&D portfolio excellence

  21. Slide 21: Dr. Richard Hausmann

    Dr. Richard Hausmann President and CEO of Elekta as of June 10, 2016 20

  22. Slide 22: Welcome to Elekta's Capital Markets Day

    Welcome to Elekta’s Capital Markets Day on June 9 in Stockholm

  23. Slide 23: Slide 23

Elekta — FY2015/16 Earnings Presentation on 6ix